XML 163 R148.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' (Deficit) Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Nov. 30, 2015
Nov. 30, 2014
Nov. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Preference stock, shares authorized (in shares) 15,000,000.0 15,000,000.0  
Preference stock, shares issued (in shares) 0 0  
Preference stock, shares outstanding (in shares) 0 0  
Common stock, shares authorized (in shares) 150,000,000.0 150,000,000.0  
Common stock, par value (in USD per share) $ 0.10 $ 0.10  
Common stock, shares issued (in shares) 62,900,000 56,900,000  
Common stock, shares outstanding (in shares) 62,900,000 56,900,000  
Number of shares reserved for future issuance 22,900,000    
Purchase of treasury stock   $ 64.5  
Expected volatility, Minimum 30.00%    
Expected volatility, Maximum 50.00%    
Risk-free interest rate, Minimum 0.21%    
Risk-free interest rate, Maximum 1.55%    
Common Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of common shares repurchased (in shares)   3,500,000  
Purchase of treasury stock   $ 64.5  
Retirement Savings Plan Contributions [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 7 years    
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 10 years    
Stock outstanding (in shares) 600,000 700,000  
Stock granted in period (in shares) 200,000   0
Weighted average grant date fair value of restricted stock granted (in USD per share)   $ 10.33  
Intrinsic value for options exercised $ 3.9 $ 0.5 $ 0.6
SARS [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock outstanding (in shares) 800,000 1,300,000  
Weighted-average grant date fair value of SARS granted (in USD per share)     $ 12.08
Stock granted in period (in shares) 0 0  
Intrinsic value paid $ 3.3 $ 1.0  
Total stock-based compensation related to nonvested SARS, less than $ 0.1    
Recognition period for compensation Cost 4 months    
SARS [Member] | Year One [Member] | Employees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting rate 33.30%    
SARS [Member] | Year Two [Member] | Employees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting rate 33.30%    
SARS [Member] | Year Three [Member] | Employees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting rate 33.30%    
SARS [Member] | After Six Months [Member] | Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting rate 50.00%    
SARS [Member] | After One Year [Member] | Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting rate 50.00%    
SARS [Member] | 1999 Plan [Member] | Employees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 10 years    
SARS [Member] | 1999 Plan [Member] | Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 10 years    
SARS [Member] | 2009 Plan [Member] | Employees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 7 years    
SARS [Member] | 2009 Plan [Member] | Director [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise stock options contractual life 7 years    
Restricted Stock, Service-Based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Recognition period for compensation Cost 16 months    
Restricted stock outstanding (in shares)   700,000  
Unrecognized compensation cost related to restricted stock $ 4.3    
Intrinsic value of restricted stock outstanding 8.3    
Intrinsic value of restricted stock which is expected to vest $ 8.0    
Weighted average grant date fair value of restricted stock granted (in USD per share) $ 20.70 $ 17.22 15.47
Restricted Stock, Service-Based [Member] | 2009 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock outstanding (in shares) 500,000    
Performance-Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Recognition period for compensation Cost 15 months    
Restricted stock outstanding (in shares)   1,200,000  
Unrecognized compensation cost related to restricted stock $ 4.7    
Intrinsic value of restricted stock outstanding 17.6    
Intrinsic value of restricted stock which is expected to vest $ 7.1    
Weighted average grant date fair value of restricted stock granted (in USD per share) $ 21.33 $ 17.25 $ 17.44
Performance-Based Restricted Stock [Member] | 2009 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock outstanding (in shares) 1,000,000    
Employee Stock Purchase Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock purchase price, percentage of fair value on last day of respective offering period (not less than) 85.00%    
Shares issued in period (in shares) 100,000    
Average price of shares issued in period (in USD per share) $ 20.61    
Employee Stock Purchase Plan [Member] | 2009 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share authorized for issuance (in shares) 1,500,000.0